Molecular Characterization of Acquired Resistance To Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients

被引：0

作者：

Bellosillo, Beatriz ^{[1
]}

Dahnases, Alba ^{[1
]}

Martinez, Alejandro ^{[1
]}

Iglesias, Mar ^{[1
]}

Gonzalez, Irio ^{[1
]}

Salido, Marta ^{[1
]}

Busto, Marcos ^{[1
]}

Sanchez, Juan ^{[1
]}

Vidal, Joana ^{[1
]}

Clave, Sergi ^{[1
]}

Moragon, Ester ^{[1
]}

Pairet, Silvia ^{[1
]}

Bellmunt, Joaquim ^{[1
]}

Serrano, Sergio ^{[1
]}

Rovira, Ana ^{[1
]}

Albanell, Joan ^{[1
]}

Montagut, Clara ^{[1
]}

机构：

[1] Hosp del Mar, Barcelona, Spain

来源：

LABORATORY INVESTIGATION | 2015年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

583

引用

页码：148A / 148A

页数：1

共 50 条

[1] Molecular Characterization of Acquired Resistance To Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients
Bellosillo, Beatriz
Dalmases, Alba
Martinez, Alejandro
Iglesias, Mar
Gonzalez, Iria
Salido, Marta
Busto, Marcos
Sanchez, Juan
Vidal, Joana
Clave, Sergi
Moragon, Ester
Pairet, Silvia
Bellmunt, Joaquim
Serrano, Sergio
Rovira, Ana
Albanell, Joan
Montagut, Clara
MODERN PATHOLOGY, 2015, 28 : 148A - 148A
[2] Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
Pietrantonio, Filippo
Vernieri, Claudio
Siravegna, Giulia
Mennitto, Alessia
Berenato, Rosa
Perrone, Federica
Gloghini, Annunziata
Tamborini, Elena
Lonardi, Sara
Morano, Federica
Picciani, Benedetta
Busico, Adele
Volpi, Chiara Costanza
Martinetti, Antonia
Battaglin, Francesca
Bossi, Ilaria
Pellegrinelli, Alessio
Milione, Massimo
Cremolini, Chiara
Di Bartolomeo, Maria
Bardelli, Alberto
de Braud, Filippo
CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2414 - 2422
[3] Heterogeneity of acquired KRAS and EGFR mutations in colorectal cancer patients treated with anti-EGFR monoclonal antibodies.
Morelli, M. Pia
Overman, Michael J.
Dasari, Arvind
Kazmi, Syed Mohammad Ali
Sanchez, Eduardo Vilar
Eng, Cathy
Kee, Bryan K.
Deaton, Laurel
Garrett, Chris R.
Diehl, Frank
Angenendt, Philipp
Kopetz, Scott
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[4] MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies
Cappuzzo, Federico
Sacconi, Andrea
Landi, Lorenza
Ludovini, Vienna
Biagioni, Francesca
D'Incecco, Armida
Capodanno, Alessandra
Salvini, Jessica
Corgna, Enrichetta
Cupini, Samanta
Barbara, Cecilia
Fontanini, Gabriella
Crino, Lucio
Blandino, Giovanni
CLINICAL COLORECTAL CANCER, 2014, 13 (01) : 37 - U62
[5] Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients
Santini, Daniele
Pantano, Francesco
Vincenzi, Bruno
Loupakis, Fotios
Caraglia, Michele
Falcone, Alfredo
Tonini, Giuseppe
EJC SUPPLEMENTS, 2008, 6 (14): : 86 - 90
[6] The effects of somatic mutations on EGFR interaction with anti-EGFR monoclonal antibodies: Implication for acquired resistance
Tabasinezhad, Maryann
Omidinia, Eskanadr
Talebkhan, Yeganeh
Omrani, Mir Davood
Mahboudi, Fereidoun
Ghaedi, Hamid
Wenzel, Wolfgang
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2020, 88 (01) : 3 - 14
[7] Blood-based molecular detection of acquired resistance to anti-EGFR therapies in colorectal cancer patients.
Siravegna, Giulia
Bianchi, Andrea Sartore
Cassingena, Andrea
Bencardino, Katia
Diaz, Luis A.
Sausen, Mark
Velculescu, Victor E.
Di Nicolantonio, Federica
Siena, Salvatore
Bardelli, Alberto
CANCER RESEARCH, 2013, 73 (08)
[8] SKIN RASH AND OUTCOME IN COLORECTAL CANCER (CRC) PATIENTS TREATED WITH ANTI-EGFR MONOCLONAL ANTIBODIES
Petrelli, F.
Borgonovo, K. F.
Cabiddu, M.
Ghilardi, M.
Cremonesi, M.
Maspero, F.
Barni, S.
ANNALS OF ONCOLOGY, 2012, 23 : 192 - 192
[9] Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?
Fakih, Marwan
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1471 - 1480
[10] Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies
Lievre, Astrid
Laurent-Puig, Pierre
PERSONALIZED MEDICINE, 2009, 6 (02) : 145 - 157

← 1 2 3 4 5 →